Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN103073399B reveals solvent-free hydrogenation for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.
Novel synthesis method for Gadoxetic acid intermediate reduces cost and improves scalability for pharmaceutical manufacturing supply chains significantly.
Advanced synthesis of macrolide antibiotic intermediates via novel epoxide ring-opening. Reduces cost and improves scalability for pharmaceutical manufacturing.
Patent CN118684600A enables efficient C-H iodination with high ee values. Discover cost-effective supply chain solutions for complex pharmaceutical intermediates.
Discover the advanced preparation method for (2S)-3-deuterium-L-valine esters disclosed in CN113461573B, offering high yield and benzene-free processing for deuterated drug manufacturing.
Novel catalytic method for diketone aminated compounds ensures high purity and yield. Ideal for pharmaceutical intermediate supply chains seeking cost reduction and scalability.
Patent CN112724082B details a cost-effective copper-catalyzed route for montelukast intermediates, offering superior purity and supply chain stability for global pharmaceutical manufacturers.
Novel palladium-catalyzed route for asymmetric imides. Neutral conditions ensure high yield and scalability for pharmaceutical intermediates manufacturing supply chains.
Patent CN112624992B reveals a purification breakthrough for risperidone intermediates. Achieve 99.9% purity and stable supply chain for API manufacturing.
Advanced purification method for Ilaprazole Sodium ensuring high purity and scalable production for global pharmaceutical supply chains.
Patent CN102127068B details a green synthesis route for Aztreonam using aqueous-alcoholic solvents, offering significant cost reduction and high purity for pharmaceutical intermediates manufacturing.
Green synthesis of 2-acylamino alkyl thiazoles via visible light. Cost-effective, mild conditions, high purity for API intermediates and supply chain optimization.
Patent CN112645982A details a scalable synthesis of Remdesivir intermediate INT using Lewis acid catalysis and perfluorinated solvent extraction for superior purity and yield.
Discover a novel palladium-catalyzed asymmetric allylic cycloaddition method for synthesizing chiral oxygen-containing eight-membered rings with high yield and enantioselectivity.
Patent CN107501280A details a novel C-H activation route for Velpatasvir. This method ensures high purity and simplifies supply chain manufacturing significantly.
Advanced preparation method for dehydroisoandrosterone via esterification and ketalization. Offers high yield, eco-friendly raw materials, and cost reduction in steroid manufacturing.
Novel bimetallic catalytic method for benzothiazole compounds ensures high yield and cost efficiency for pharmaceutical supply chains.
Novel patent CN106892860A details a cost-effective, scalable route for Alectinib intermediates, offering significant supply chain advantages for API manufacturing.
Novel benzaldehyde derivative route for Galanthamine. Mild conditions, scalable Suzuki coupling, efficient chiral resolution. Cost-effective API intermediate manufacturing.
Patent CN108892683B discloses a novel reduction method for 2,6-diiodo BODIPY derivatives, enabling efficient nanomaterial modification and enhanced photodynamic therapy applications.